Navigation Links
Akela Pharma Inc. Completes Share Consolidation
Date:10/9/2007

http://www.akelapharma.com Toronto Stock Exchange Symbol: AKL

MONTREAL, Oct. 9 /PRNewswire-FirstCall/ - AKELA Pharma Inc., (TSX: AKL), a drug development company focused on developing therapies for the inhalation, pain and CNS markets, today announced that effective October 10, 2007, its issued and outstanding common shares will be consolidated on the basis of one (1) post-consolidation common share for every seven (7) pre-consolidation common shares. Fractional interests will be paid in cash in U.S. dollars for shareholders other than those in Canada who will be paid in Canadian dollars. The common shares will commence trading on the Toronto Stock Exchange on a post-consolidated basis at the opening of trading on October 10, 2007.

The share consolidation has been effected to satisfy the NASDAQ's listing criteria regarding minimum bid price. After the share consolidation, the Company will have approximately 11.75 million common shares outstanding. The stock symbol of the Company will remain AKL on the TSX.

About Akela Pharma Inc.

Akela Pharma is an integrated drug development company focused on developing therapies for the growing multi-billion dollar inhalation, pain and CNS markets. Its lead product, for the treatment of breakthrough cancer pain, is a fast-acting Fentanyl formulation delivered using the Company's TAIFUN(R) dry powder inhaler platform. Its pipeline also includes therapeutics for asthma, COPD, growth hormone deficiencies and controlled substance abuse deterrent formulations.

Akela's common shares trade on The Toronto Stock Exchange ("TSX") under the symbol "AKL" with 82.3 million shares outstanding.

This news release contains certain forward-looking statements that reflect the current views and/or expectations of AKELA Pharma Inc. with respect to its performance, business and future events. Such statements are subject to a number of risks, uncer
'/>"/>

SOURCE Akela Pharma Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. India to benefit from pharma companies move
2. South Africa Wins landmark case against pharmaceutical giants
3. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
4. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
5. Pharma cos must forge Strategic alliances
6. Jharkhand Pharmacies Refuse To Sell Viagra
7. Setting up a new pharmaceutical industry in India
8. Medicis Pharmaceutical company enters pediatric market
9. Supply of Radiopharmaceuticals Hampered by Attacks
10. Pharma majors gear to supply anti-anthrax drug
11. Pharmacies in for a dose of bitter medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)...A cleanroom manufacturing company has introduced a...he feature is a utility panel which can be integra...nroom appearance. , Burns...eering, a designer, fabricator and installer of cl... offering a utility panel for integration into its...
(Date:7/24/2008)...swire-FirstCall/ --, Key Highlights, Misys plc (...nd is now,raising targets for the next phase of th... GBP492m up 6%, bringing Group operating profit(2)...ting on its strategy and entering,into the next ph...r growth., To view the Multimedia News Release, p...
(Date:7/23/2008)...d for better physician-administration relations ...sicians, SOUTH BEND, Ind., July 24 /PRNewswire/ -...eport: Physician Perspectives on American Hospital...ysician-administration,relationship, and physician...onsive to the ideas and needs of medical staff. Th...
(Date:7/23/2008)... welcome to out-of-state intended parents, SAN RA...lifornia,Supreme Court decision to allow gay coupl...oductive Science Center of the Bay Area (RSC), one...rving gays and lesbians for,infertility treatment.... supports RSC,s,long-held views that procreation i...
Breaking Medicine News(10 mins):Health News:Gerbig Engineering Announces Availability of Cleanroom Utility Panel 2Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 2Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 3Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 4Health News:Authoritative Report on Physician Perspectives Released Today 2Health News:California Supreme Court Gay-Marriage Ruling Reinforces Top Bay Area Fertility Specialists' Support for Same-Sex Couples 2
...ion will decide later this month whether internet ...octors will vote on the issue at the AMA national ... disease is teens holing up in their rooms, ignori...n food and a shower, while grades plummet and bell...
...e environments on the planet, the airplane, is abo...bile phone calls at high altitude. Requests to swi...miliar part of the takeoff routine for airline pas...d a way to make dialling safe and link up people f...
...Governments measures to address Indigenous child a...cepts the Prime Ministers invitation for the AMA t...ergency. AMA President, Dr Rosanna Capolingua, sai...iefing from the Prime Ministers office and the Hea...
...gh levels of urate in the blood is linked to a red...ucted by researchers at the Harvard School of Publ...tant Professor of Environmental and Occupational E...a normal component of blood, and although high lev...
Other Medicine News:Health News:Video Game Addiction to Be Termed as a Medical Condition 2Health News:'Hi, can You Hear Me? I'm at 30,000 Feet' 2Health News:'Hi, can You Hear Me? I'm at 30,000 Feet' 3Health News:Indigenous Child Abuse 2Health News:High Urate Levels in Blood Linked to Reduced Parkinson's Risk 2
(Date:7/22/2008)...ch Innovative Laser Lipolysis Technology in the Eu...TFORD, Mass., July 22 /- Cy... and manufacturer of a broad array of,light-based ...pean CE Mark,for Smartlipo MPX(TM), the company,s ...n to liquefy fat and tighten skin through collagen...
(Date:7/22/2008)...es an Individual,s Genetic Risk Based on Clinical ...c Educational Materials, WALTHAM, Mass., July 22 ...c. (Amex: ILI ), today announced the launch of an...ge for the company,s Heart Health Genetic Test.,Th...Gensona(R) Heart Health,Genetic Test by Quixtar/Am...
(Date:7/21/2008)... to focus on use of Zevalin as consolidation thera...ted patients with follicular ...FirstCall/ -- Cell Therapeutics, Inc.,(CTI) (Nasda...has scheduled,a meeting with the U.S. Food and Dru... possibility of filing a supplemental Biologics Li...
(Date:7/21/2008)...21 /- The University of Oxford Clinic...Unit (CTSU) proposed that the,hypothesis-generatin...,tested by reviewing the combined cancer results f...and reporting on the overall findings to,the relev...rug,manufacturers., The two hypothesis-testing tr...
Breaking Medicine Technology:Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation 2Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation 3Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format 2Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format 3CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 2CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 3CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R) 4Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of Ezetimibe 2Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of Ezetimibe 3The Ocean Becomes a Pipeline To A Cure for Cystic Fibrosis 2606 1The Ocean Becomes a Pipeline To A Cure for Cystic Fibrosis 2606 2The Ocean Becomes a Pipeline To A Cure for Cystic Fibrosis 2606 3UAB joins elite brain cancer research group 23605 1UAB joins elite brain cancer research group 23605 2Lehigh to lead 249 6M national research center for serious behavior disorders 23603 1Lehigh to lead 249 6M national research center for serious behavior disorders 23603 2Lehigh to lead 249 6M national research center for serious behavior disorders 23603 3LSUHSC awarded 2410M+ COBRE grant 3966 1LSUHSC awarded 2410M+ COBRE grant 3966 2LSUHSC awarded 2410M+ COBRE grant 3966 3LSUHSC awarded 2410M+ COBRE grant 3966 4
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide l...pment. ARUP offers an extensive test menu of highl... anatomic pathology. Owned by the University of Ut...alf of the nation's university teaching hospitals ...
Medicine Products: